Treatment of hyperlipidemia by specialists versus generalists as secondary prevention of coronary artery disease.
Patients with known coronary disease and low-density lipoprotein >130 mg/dl who are followed by cardiologists after myocardial infarction are more than twice as likely to receive a cholesterol-lowering agent than patients followed by general internists.